DDS earnings analysis
What we found in DDS's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.
Our reading of the filing · Free to read, no account needed
The supplied 10-Q excerpt contains no income statement, balance-sheet, cash-flow, or segment results, so period-over-period operating trends cannot be independently assessed from the filing text provided. Controls were effective, with 0 material internal-control changes and no material legal proceedings identified. Share-class conversions totaled 184,442 shares during the quarter, while share repurchases were 0 and $165.2 million remained available under the repurchase authorization.
The parts that mattered.
Pulled out of the filing itself, with the figures the company reported.
- Controls remained effective
- Management concluded that disclosure controls and procedures were effective as of the quarter end, and reported 0 changes in internal control over financial reporting that materially affected or were reasonably likely to materially affect the company.
- Repurchase authorization preserved
- The company repurchased 0 shares during the three months ended August 1, 2026, leaving $165.2 million of authorization under the May 2023 Stock Plan.
- Share-class conversions continued
- Dillard’s issued 184,442 Class A shares in exchange for 184,442 Class B shares during the quarter; it issued an additional 41,850 Class A shares after quarter end on August 19, 2026.
And the other side of it.
The offsets in the same document — the things a summary that only listed the good news would have left out.
- No updated market-risk detail
- The company reported 0 material changes to the market-risk disclosures from the January 31, 2026 Form 10-K, but the filing provides no new quantitative sensitivity information.
- Ongoing ordinary-course litigation
- As of September 4, 2026, Dillard’s reported 0 legal proceedings expected, individually or in aggregate, to have a material adverse effect; ordinary-course litigation remains possible.
- No quarterly share repurchases
- The May 2023 Stock Plan had $165.2 million of unused authorization as of August 1, 2026, but 0 shares were repurchased during the quarter, providing no evidence of current repurchase support.
What they said about what is next.
No quantitative EPS or revenue guidance was provided in the supplied 10-Q text. The filing states there were no material changes to market-risk disclosures and no material changes to risk factors.
The filing reads about the same as the one before it.
What came before.
- 10-Q · June 5, 2026
- Dillard's, Inc. reported a strong Q1 2026, with revenue of $1.568 billion and EPS of $16.04, marking increases of 2.6% and 54% respectively year-over-year. Notably, the company benefitted from a legal settlement that…
- 10-K · March 27, 2026
- Dillard’s reports roughly stable sales over the last two fiscal years with resilient margins and strong cash generation. Fiscal 2026 quarterly results sum to about $6.57B in revenue with gross and operating margins…
- 10-Q · June 6, 2025
- Dillard’s reported a modest YoY revenue decline with durable margins and strong cash generation. Net sales plus service income were $1,546,971,000 and net income was $163,817,000 ($10.39 per share), with operating cash…
- 10-K · March 28, 2025
- Dillard’s 2025 10‑K shows a regional department‑store business with pronounced seasonality (Q4 ≈ one‑third of annual sales) and a heavy focus on private‑label merchandise and a 10‑year Citibank credit‑card alliance.…
This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.
Read the next one first.
We read every filing DDS makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.
Cancel anytime · Month to month · Switch tiers whenever